2Seventy Bio Inc

General ticker "TSVT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $185.7M

2Seventy Bio Inc follows the US Stock Market performance with the rate: 1.5%.

Estimated limits based on current volatility of 4.5%: low 2.84$, high 3.11$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.12$, 6.07$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.38$, 6.16$]

Financial Metrics affecting the TSVT estimates:

  • Negative: Non-GAAP EPS, $ of -4.02 <= 0.10
  • Negative: Operating profit margin, % of -68.34 <= 1.03
  • Negative: Operating cash flow per share per price, % of -53.83 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0 <= 0
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term TSVT quotes

Long-term TSVT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $54.52MM $91.50MM $100.39MM
Operating Expenses $368.03MM $354.40MM $317.09MM
Operating Income $-313.51MM $-262.91MM $-216.70MM
Non-Operating Income $21.30MM $8.76MM $-0.87MM
R&D Expense $261.94MM $248.74MM $230.76MM
Income(Loss) $-292.21MM $-254.15MM $-217.57MM
Taxes $-16.00MM $-0.01MM $0.00MM
Profit(Loss) $-276.21MM $-254.14MM $-217.57MM
Stockholders Equity $359.82MM $310.47MM $255.30MM
Inventory $114.12MM $13.64MM $0.00MM
Assets $759.67MM $656.66MM $565.43MM
Operating Cash Flow $-206.85MM $-228.14MM $-166.86MM
Capital expenditure $19.57MM $22.84MM $13.87MM
Investing Cash Flow $-17.59MM $3.75MM $43.86MM
Financing Cash Flow $354.89MM $166.23MM $127.39MM
Earnings Per Share* $-11.71 $-7.13 $-4.42

* EPS are Split Adjusted, recent splits may be reflected with a delay.